SE0101854L - Användning av en förening med en negativt laddad region av grupper för behandling av restenos. - Google Patents
Användning av en förening med en negativt laddad region av grupper för behandling av restenos.Info
- Publication number
- SE0101854L SE0101854L SE0101854A SE0101854A SE0101854L SE 0101854 L SE0101854 L SE 0101854L SE 0101854 A SE0101854 A SE 0101854A SE 0101854 A SE0101854 A SE 0101854A SE 0101854 L SE0101854 L SE 0101854L
- Authority
- SE
- Sweden
- Prior art keywords
- negatively charged
- restenosis
- compound
- groups
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0101854A SE0101854L (sv) | 2001-05-28 | 2001-05-28 | Användning av en förening med en negativt laddad region av grupper för behandling av restenos. |
DE60230134T DE60230134D1 (de) | 2001-05-28 | 2002-05-28 | Verwendung einer verbindung mit einer negativ geladenen domäne von phosphor-enthaltenden radikalen für die behandlung von restenosis |
US10/478,962 US20040235799A1 (en) | 2001-05-28 | 2002-05-28 | Use of a compound with a negatively charged domain of radicals for the treatment of restenosis |
JP2002592945A JP2004532872A (ja) | 2001-05-28 | 2002-05-28 | 再狭窄の治療のためにラジカルの負に帯電されたドメインをもった化合物の使用 |
DK02733745T DK1390045T3 (da) | 2001-05-28 | 2002-05-28 | Anvendelse af en forbindelse med et negativt ladet domæne af phosphorholdige radikaler til behandling af restenose |
EP02733745A EP1390045B1 (en) | 2001-05-28 | 2002-05-28 | The use of a compound with a negatively charged domain of phosphorous-containing radicals for the treatment of restenosis |
AT02733745T ATE415975T1 (de) | 2001-05-28 | 2002-05-28 | Verwendung einer verbindung mit einer negativ geladenen domäne von phosphor-enthaltenden radikalen für die behandlung von restenosis |
ES02733745T ES2316568T3 (es) | 2001-05-28 | 2002-05-28 | Uso de un compuesto con un dominio cargado negativamente de radicales que contiene fosforo para el tratamiento de reestenosis. |
PCT/SE2002/001016 WO2002096436A1 (en) | 2001-05-28 | 2002-05-28 | The use of a compound with a negatively charged domain of radicals for the treatment of restenosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0101854A SE0101854L (sv) | 2001-05-28 | 2001-05-28 | Användning av en förening med en negativt laddad region av grupper för behandling av restenos. |
Publications (2)
Publication Number | Publication Date |
---|---|
SE0101854D0 SE0101854D0 (sv) | 2001-05-28 |
SE0101854L true SE0101854L (sv) | 2002-11-29 |
Family
ID=20284248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0101854A SE0101854L (sv) | 2001-05-28 | 2001-05-28 | Användning av en förening med en negativt laddad region av grupper för behandling av restenos. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20040235799A1 (sv) |
EP (1) | EP1390045B1 (sv) |
JP (1) | JP2004532872A (sv) |
AT (1) | ATE415975T1 (sv) |
DE (1) | DE60230134D1 (sv) |
DK (1) | DK1390045T3 (sv) |
ES (1) | ES2316568T3 (sv) |
SE (1) | SE0101854L (sv) |
WO (1) | WO2002096436A1 (sv) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI20021570A0 (sv) * | 2002-09-03 | 2002-09-03 | Gallen Kallela Siren Janne | Förbättrad konstruktion av en belagd kirurgisk stent |
US10159297B2 (en) * | 2013-05-21 | 2018-12-25 | Bradford C. Jamison | Patterned plexus of filaments, method of producing and articles containing patterned filaments |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5128332A (en) * | 1984-10-23 | 1992-07-07 | Perstorp Ab | Method of treating cardiovascular diseases using inositoltrisphosphate |
US5389620A (en) * | 1993-08-18 | 1995-02-14 | Banyu Pharmaceutical Co., Ltd. | Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives |
US5753230A (en) * | 1994-03-18 | 1998-05-19 | The Scripps Research Institute | Methods and compositions useful for inhibition of angiogenesis |
IT1275935B1 (it) * | 1995-03-17 | 1997-10-24 | Chiesi Farma Spa | Derivato di aminotetralina per la terapia di malattie cardiovascolari |
US6846839B1 (en) * | 1995-06-07 | 2005-01-25 | Sugen, Inc. | Methods for treating diseases and disorders related to unregulated angiogenesis and/or vasculogenesis |
CA2166155C (en) * | 1995-12-27 | 2008-02-05 | Eva Anne Turley | Agents binding to hyaluronic acid binding domains and the use thereof |
US20040063790A1 (en) * | 1996-05-31 | 2004-04-01 | The Scripps Research Institute | Methods for inhibition of angiogenesis |
AUPO888497A0 (en) * | 1997-09-01 | 1997-09-25 | Australian National University, The | Use of sulfated oligosaccharides as inhibitors of cardiovascular disease |
US6896659B2 (en) * | 1998-02-06 | 2005-05-24 | Point Biomedical Corporation | Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility |
US6685938B1 (en) * | 1998-05-29 | 2004-02-03 | The Scripps Research Institute | Methods and compositions useful for modulation of angiogenesis and vascular permeability using SRC or Yes tyrosine kinases |
US6028061A (en) * | 1998-06-18 | 2000-02-22 | Children's Medical Center Corp | Angiogenesis inhibitors and use thereof |
US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
AU6409499A (en) * | 1998-10-01 | 2000-04-17 | Children's Medical Center Corporation | Method of treatment of cardiovascular injuries |
US6573096B1 (en) * | 2000-04-01 | 2003-06-03 | The Research Foundation At State University Of New York | Compositions and methods for inhibition of cancer invasion and angiogenesis |
US7019108B2 (en) * | 2001-06-01 | 2006-03-28 | University Of Southern California | Method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2 |
WO2004096832A2 (en) * | 2003-04-29 | 2004-11-11 | Children's Medical Center Corporation | Novel antiangiogenic peptides |
JP3958309B2 (ja) * | 2004-08-23 | 2007-08-15 | 株式会社名機製作所 | 射出成形機 |
-
2001
- 2001-05-28 SE SE0101854A patent/SE0101854L/sv not_active Application Discontinuation
-
2002
- 2002-05-28 US US10/478,962 patent/US20040235799A1/en not_active Abandoned
- 2002-05-28 JP JP2002592945A patent/JP2004532872A/ja active Pending
- 2002-05-28 AT AT02733745T patent/ATE415975T1/de not_active IP Right Cessation
- 2002-05-28 EP EP02733745A patent/EP1390045B1/en not_active Expired - Lifetime
- 2002-05-28 WO PCT/SE2002/001016 patent/WO2002096436A1/en active Application Filing
- 2002-05-28 DK DK02733745T patent/DK1390045T3/da active
- 2002-05-28 DE DE60230134T patent/DE60230134D1/de not_active Expired - Lifetime
- 2002-05-28 ES ES02733745T patent/ES2316568T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1390045B1 (en) | 2008-12-03 |
WO2002096436A1 (en) | 2002-12-05 |
ATE415975T1 (de) | 2008-12-15 |
SE0101854D0 (sv) | 2001-05-28 |
EP1390045A1 (en) | 2004-02-25 |
DE60230134D1 (de) | 2009-01-15 |
ES2316568T3 (es) | 2009-04-16 |
DK1390045T3 (da) | 2009-02-23 |
JP2004532872A (ja) | 2004-10-28 |
US20040235799A1 (en) | 2004-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20063831B (en) | Substituted bicyclic derivatives for treatment of abnormal cell growth | |
BG108268A (en) | Pyrazolopyrimidines as therapeutic agents | |
BG108269A (en) | Pyrazolopyrimidines as therapeutic agents | |
DE60030741D1 (de) | Chinazoline verbindungen als heilmittel | |
BG106586A (en) | Pyrazolopyramidines as therapeutic agents | |
MY140031A (en) | Carbonyl compounds | |
ECSP055809A (es) | Inhibidores 4-oxo-1-(3-fenil sustituido)-1,4-dihidro-1,8-naftiridina-3-carboxamida de la fosfodiesterasa-4 | |
NO20055655D0 (no) | Anvendelse av azetidinkarboksamidderivater i terapi | |
SE0301232D0 (sv) | Novel use | |
NO20032027D0 (no) | Effektive antitumorbehandlinger | |
CY1107465T1 (el) | Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων | |
DK1390371T3 (da) | Oxazolo- og furopyrimidiner samt deres anvendelse i lægemidler mod tumorer | |
ES2157252T3 (es) | Aplicacion del riluzol en el tratamiento del neuro-sida. | |
SE9802208D0 (sv) | Novel compounds | |
PT1030667E (pt) | Utilizacao de mirtazapina para o fabrico de um medicamento para o tratamento de apenas do sono | |
SE0101854L (sv) | Användning av en förening med en negativt laddad region av grupper för behandling av restenos. | |
NZ528164A (en) | Use of flumazenil to produce a medicament for the treatment of cocaine dependency | |
EE200200088A (et) | Bis-sulfoonamiidide kasutamine ravimite valmistamiseks, mis on ette nähtud hüperlipideemia ärahoidmiseks või raviks | |
SE9802209D0 (sv) | Novel compounds | |
HK1044467A1 (en) | Use of polycyclic thiazole systems for producing medicaments for preventing or treating obesity | |
NO20054034L (no) | Fremgangsmate for behandling av hypotyroidisme. | |
SE0002739D0 (sv) | New use | |
DE60221104D1 (de) | Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptose | |
MXPA05008833A (es) | D-homoestra-1,3,5(10)-trien-3-il-sulfamatos 2-sustituidos con actividad antitumoral. | |
RS52038B (en) | USE OF 7-BUTOXYIMINOMETHYLAMPTOTECIN FOR THE TREATMENT OF NON-PLASMA NEOPLASMS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |